IP Library Granted Patent US 9,512,428
Granted Patent B2
US 9,512,428 · App. 14/822,099 · Granted Dec 6, 2016

Method of deriving mature hepatocytes from human embryonic stem cells

Inventors: Srikumar Sengupta (Madison, WI); James Thomson (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C12N15/113A61K35/407A61K35/545C12N5/067C12N5/0672C12N15/111G01N33/5014A61K38/38A61K38/44A61K38/45A61K38/57C12N2310/141C12N2320/30C12N2501/65C12N2510/00C12Y114/13017C12Y114/14001C12Y206/01005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,512,428
App. No.
14/822,099
Granted
Dec 6, 2016
Kind
B2
Abstract

A method for producing mature hepatocytes having functional hepatic enzyme activity from human pluripotent cells is disclosed. The method includes the step of transferring an external vector comprising the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-122, the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-let-7c, a microRNA having the seed sequence of the microRNA miR-122, a microRNA having the seed sequence of the microRNA miR-let-7c, or a combination thereof into one or more fetal hepatocytes. The resulting cells differentiate into mature hepatocytes that exhibit functional hepatic enzyme activity, and can be used in drug metabolism and toxicity testing, in the study of viruses that target hepatic tissue, and as therapeutics. A related method of maintaining the functional hepatic enzyme activity of primary hepatocytes over time is also disclosed. The method includes the step of transferring an external vector comprising the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-122 into one or more cultured primary hepatocytes.

Claims (8)

1. A culture comprising one or more isolated mature hepatocytes, wherein after nine days of culture, at least one of the hepatocytes maintains expression levels of tyrosine aminotransferase (TAT) that is at least 80% of the level that was exhibited when the culture was established, wherein the cells are expressing an exogenous sequence comprising

(a) a first microRNA comprising a core sequence that is 18 to 24 nucleotides long, wherein the 10 nucleotide sequence on the 5′ end of the core sequence comprises a seed sequence consisting of any 6, 7, 8, 9 or 10 consecutive nucleotides of SEQ ID NO:5; or

(b) an external vector comprising a DNA sequence coding for the first microRNA; or

(c) a second microRNA comprising a core sequence that is 18 to 24 nucleotides long; wherein the 10 nucleotide sequence on the 5′ end of the core sequence comprises a seed sequence consisting of any 6, 7, 8, 9 or 10 consecutive nucleotides of SEQ ID NO:6; or

(d) an external vector comprising a DNA sequence coding for the second microRNA; or

(e) two or more of (a)-(d).

2. The culture of claim 1 , wherein the first microRNA comprises the nucleotide sequence of SEQ ID NO:2 or SEQ ID NO:1.

3. The culture of claim 1 , wherein the second microRNA comprises the nucleotide sequence of SEQ ID NO:4 or of SEQ ID NO:3.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2015
From: THOMSON, JAMES; SENGUPTA, SRIKUMAR
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 036666/0474 →
Continuity (5)
Division 13772802 · Feb 21, 2013
Provisional Application 61706327 · Sep 27, 2012
Provisional Application 61647090 · May 15, 2012
Provisional Application 61601128 · Feb 21, 2012
Related Publication 20160032287A1 · Feb 4, 2016